Skip to main content
2025 Canadian Cardiovascular Congress Main banner

Genetics

Electrophysiology

Heart Failure

Canadian Heart Rhythm Society (CHRS)
Session Type: Workshop

421 - DIAGNOSIS AND MANAGEMENT OF HIGH-RISK GENETIC CARDIOMYOPATHIES

Sunday, October 26, 2025
10:00am - 11:00am ET
Room:308AB

Target Audience: Heart failure specialists, Trainee (clinical), Electrophysiologists

Workshop Description: Genetic cardiomyopathies represent a heterogeneous family of nonischemic cardiomyopathies. The risk of sudden cardiac death or progression towards end-stage heart failure is highly dependent on the underlying genetic substrate. Given their rarity and the complexity of their management, most cardiologists have very little clinical experience with genetic cardiomyopathies.

This workshop will provide participants with a comprehensive and practical approach to diagnosis and management of patients with genetic cardiomyopathies.

The CHRS education committee planned this workshop. Members of this committee include community and academic cardiologists, electrophysiologists, cardiology residents and allied professionals from diverse practices and experience across Canada. The CHRS education committee is composed of representatives from each of the following regions: British Colombia, Prairies, Ontario, Quebec, Atlantic Provinces.

The CHRS education committee has developed an objective and balanced representation of the topic of " Diagnosis and Management of High-Risk Genetic Cardiomyopathies" that is completely free of third-party influence and/or support. A meeting was planned to assess the needs of clinical cardiologists, trainees and internists in the field of arrhythmia management. Selected speakers are representative of diversity in gender and generation as well as the perspective from across Canada.

Interactive and Engagement Activities Description
Each speaker will open with a case presentation relevant to the topic assigned. Each presentation will last 12 minutes and include 3 question-and-answer to promote interactive learning via audience response system. Each presentation will last 12 minutes which will allow for 36 minutes of presentations and 14 minutes of discussion.

Learning Objectives:

At the end of this session participants will be able to:
  • appreciate the utility of cardiac magnetic resonance imaging as part of standard diagnostic work-up for the diagnosis and risk stratification in patients with nonischemic, dilated cardiomyopathy;
  • identify the gene-dependent variability in the response of heart failure treatment and in the overall prognosis of patients with hereditary cardiomyopathies; and
  • appreciate the complexity of SCD risk stratification in patients with hereditary cardiomyopathy requiring an individualized, gene-dependent assessment.

Back to Top